Advanced Life Sciences Company Description
Advanced Life Sciences is a biopharmaceutical company working to develop clinical and preclinical drug candidates for infectious disease, cancer, and inflammation. Its antibiotic candidate cethromycin is in clinical trials for treatment of respiratory infections and pneumonia. The biopharmaceutical company's other drug candidates include possible treatments for metastatic melanoma and inflammation-related tissue damage as a result of acute respiratory distress syndrome. The company has licensed the development and commercialization rights to cethromycin from Abbott Laboratories.
View the Comprehensive Company Description for Advanced Life Sciences
The Company Description provides a historical perspective of Advanced Life Sciences's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Advanced Life Sciences's evolution in the marketplace.
